THE IMPACT OF TOXOPLASMA GONDII INFECTION ON THE VITAMIN D3 LEVELS AMONG WOMEN IN CHILDBEARING AGE TREATMENT AND EFFECT ON FETAL BRAIN DEVELOPMENT

http://dx.doi.org/10.31703/gdddr.2022(VII-II).04      10.31703/gdddr.2022(VII-II).04      Published : Jun 2
Authored by : Sikandar Ali Khan , Erum Rehman , Muhammad BilalKhattak , Zakia Subhan , Sara YarKhan , Zahid Irfan Marwat

04 Pages : 22-32

References

  • Al-Adhroey, A. H., Mehrass, A. A. K. O., Al- Shammakh, A. A., Ali, A. D., Akabat, M. Y. M., & Al-Mekhlafi, H. M. (2019). Prevalence and predictors of Toxoplasma gondii infection in pregnant women from Dhamar, Yemen. BMC Infectious Diseases, 19(1), 1089. https://doi.org/10.1186/s12879-019-4718-4
  • Al-Qadi et al., (2019). Effect of Pregnancy on Some Biochemicaland Immunological Measures for Women with Toxoplasma Gondii. Biochem. Cell. Arch., 19(1), 761-765. DOI: 10.35124/bca.2019.19.1.761
  • Cenci-Goga, B. T., Rossitto, P. V., Sechi, P., McCrindle, C. M., & Cullor, J. S. (2011). Toxoplasma in Animals, Food, and Humans: An Old Parasite of New Concern. Foodborne Pathogens and Disease, 8(7), 751– 762. https://doi.org/10.1089/fpd.2010.0795
  • Darling, A. L., Rayman, M. P., Steer, C. D., Golding, J., Lanham-New, S. A., & Bath, S. C. (2017). Association between maternal VD status in pregnancy and neurodevelopmental outcomes in childhood: results from the Avon Longitudinal Study of Parents and Children (ALSPAC). British Journal of Nutrition, 117(12), 1682-1692.
  • Deschasaux, M., Souberbielle, J. C., Partula, V., Lécuyer, L., Gonzalez, R., Srour, B., Guinot, C., Malvy, D., Latino-Martel, P., Druesne- Pecollo, N., Galan, P., Hercberg, S., Kesse- Guyot, E., Fassier, P., Ezzedine, K., & Touvier, M. (2016). What Do People Know and Believe about Vitamin D? Nutrients, 8(11), 718. https://doi.org/10.3390/nu8110718
  • Elbahaie, E., Yousef, A., & Omar, M. (2022). Vitamin D3: Emerging Role in Murine Toxoplasmosis. Afro-Egyptian Journal of Infectious and Endemic Diseases, 12(1), 24-33. https://doi.org/10.21608/aeji.2021.96146.1180
  • Eyles, D., Burne, T., & McGrath, J. (2011, August). VD in fetal brain development. In Seminars in cell & developmental biology (Vol. 22, No. 6, pp. 629-636). Academic Press.
  • Fitzgerald, E., Hor, K., & Drake, A. J. (2020). Maternal influences on fetal brain development: The role of nutrition, infection and stress, and the potential for intergenerational consequences. Early Human Development, 150, 105190. https://doi.org/10.1016/j.earlhumdev.2020.105190
  • Gale, C. R., Robinson, S. M., Harvey, N. C., Javaid, M. K., Jiang, B., Martyn, C. N., ... & Cooper, C. (2008). Maternal VD status during pregnancy and child outcomes. European journal of clinical nutrition, 62(1), 68-77.
  • Goldstein, E. J., Montoya, J. G., & Remington, J. S. (2008). Management of Toxoplasma gondii infection during pregnancy. Clinical infectious diseases, 47(4), 554-566.
  • Hebert, K. J., Miller, L. L., & Joinson, C. J. (2010). Association of autistic spectrum disorder with season of birth and conception in a UK cohort. Autism Research, 3(4), 185– 190. https://doi.org/10.1002/aur.136
  • Hollis BW, Wagner CL. (2006). VD deficiency during pregnancy: an ongoing epidemic. Am J Clin Nutr., 84(2), 273.
  • Kim, H., Hong, S. H., Jeong, H. E., Han, S., Ahn, J., Kim, J. A., Yang, J. H., Oh, H. J., Chung, S., & Lee, S. E. (2022). Microfluidic model for in vitro acute Toxoplasma gondii infection and transendothelial migration. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-15305-4
  • Kinney, D. K., Hintz, K., Shearer, E. M., Barch, D. H., Riffin, C., Whitley, K., & Butler, R. (2010). A unifying hypothesis of schizophrenia: Abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction. Medical Hypotheses, 74(3), 555–563. https://doi.org/10.1016/j.mehy.2009.09.040
  • Kourtis, A. P., Read, J. S., & Jamieson, D. J. (2014). Pregnancy and Infection. New England Journal of Medicine, 370(23), 2211– 2218. https://doi.org/10.1056/nejmra1213566
  • Laboudi, M., Taghy, Z., Duieb, O., Peyron, F., & Sadak, A. (2021). Toxoplasma gondii seroprevalence among pregnant women in Rabat, Morocco. Tropical Medicine and Health, 49(1), 21-30. https://doi.org/10.1186/s41182-021-00311-5
  • Laird, E., Thurston, S. W., Van Wijngaarden, E., Shamlaye, C. F., Myers, G. J., Davidson, P. W., ... & Strain, J. J. (2017). Maternal VD status and the relationship with neonatal anthropometric and childhood neurodevelopmental outcomes: results from the Seychelles Child Development Nutrition Study. Nutrients, 9(11), 1235-1275.
  • McCann, J. C., & Ames, B. N. (2008). Is there convincing biological or behavioral evidence linking VD deficiency to brain dysfunction? FASEB J., 22(4), 982–1001.
  • Messerer, L., Bouzbid, S., & Gourbdji, E. et al. (2014). Séroprévalence de la toxoplasmose chez les femmes enceintes dans la wilaya d’Annaba, Algérie (Seroprevalence of toxoplasmosis in pregnant women in Annaba, Algeria). Rev Epidemiol Sante Publique, 62(2), 160–165.
  • Mirza Alizadeh, A., Jazaeri, S., Shemshadi, B., Hashempour-Baltork, F., Sarlak, Z., Pilevar, Z., & Hosseini, H. (2018). A review on inactivation methods of Toxoplasma gondii in foods. Pathogens and Global Health, 112(6), 306– 319. https://doi.org/10.1080/20477724.2018.1514137
  • Morales, E., Julvez, J., Torrent, M., Ballester, F., Rodriguez-Bernal, C. L., Andiarena, A., ... & Sunyera, J. (2015). VD in pregnancy and attention deficit hyperactivity disorder-like symptoms in childhood. Epidemiology, 26(4), 458-465.
  • Nazir, M. M., Akhtar, M., Maqbool, A., Waheed, A., Sajid, M. A., Ali, M. A., Oneeb, M., Alam, M. A., Ahmad, A. N., Nazir, N., Fatima, S., & Lindsay, D. S. (2017). Antibody Prevalence and Risk Factors for Toxoplasma gondiiInfection in Women from Multan, Pakistan. Zoonoses and Public Health, 64(7), 537–542. https://doi.org/10.1111/zph.12336
  • Pérez-López, F. R., Pilz, S., & Chedraui, P. (2020). VD supplementation during pregnancy: an overview. Current Opinion in Obstetrics and Gynecology, 32(5), 316-321.
  • Rasheed, Z., Shariq, A., AlQefari, G. B., Alwahbi, G. S., Aljuaythin, A. I., Alsuhaibani, F. S., Alotaibi, D. F., Aljohani, S. S., Alghasham, R., Alsaeed, T., Alharbi, N. A., Rugaie, O. A., Abdulmonem, W. A., & Sharaf, O. F. (2021). Toxoplasmosis in immunocompetent Saudi women: Correlation with vitamin D. Women’s Health, 17, 174550652110438. https://doi.org/10.1177/17455065211043844
  • Robert-Gangneux, F., & Darde, M. L. (2012). Epidemiology of and Diagnostic Strategies for Toxoplasmosis. Clinical Microbiology Reviews, 25, 264-296. https://doi.org/10.1128/CMR.05013-11
  • Sappenfield, E., Jamieson, D. J., & Kourtis, A. P. (2013). Pregnancy and Susceptibility to Infectious Diseases. Infectious Diseases in Obstetrics and Gynecology, 2013, 1– 8. https://doi.org/10.1155/2013/752852
  • Wagner, C. L., McNeil, R. B., Johnson, D. D., Hulsey, T. C., Ebeling, M., Robinson, C., ... & Hollis, B. W. (2013). Health characteristics and outcomes of two randomized VD supplementation trials during pregnancy: a combined analysis. The Journal of steroid biochemistry and molecular biology, 136, 313-320.
  • Whitehouse, A. J., Holt, B. J., Serralha, M., Holt, P. G., Kusel, M. M., & Hart, P. H. (2012). Maternal serum VD levels during pregnancy and offspring neurocognitive development. Pediatrics, 129(3), 485-493.
  • Willer, C. J., Dyment, D. A., Sadovnick, A. D., Rothwell, P. M., Murray, T. J., & Ebers, G. C. (2004). Timing of birth and risk of multiple sclerosis: population based study. BMJ, 330(7483), 120. https://doi.org/10.1136/bmj.38301.686030.63
  • Zhou, P., Chen, Z., Li, H. L., Zheng, H., He, S., Lin, R. Q., & Zhu, X. Q. (2011). Toxoplasma gondii infection in humans in China. Parasites &Amp; Vectors, 4(1). ttps://doi.org/10.1186/1756-3305-4-165

References

  • Al-Adhroey, A. H., Mehrass, A. A. K. O., Al- Shammakh, A. A., Ali, A. D., Akabat, M. Y. M., & Al-Mekhlafi, H. M. (2019). Prevalence and predictors of Toxoplasma gondii infection in pregnant women from Dhamar, Yemen. BMC Infectious Diseases, 19(1), 1089. https://doi.org/10.1186/s12879-019-4718-4
  • Al-Qadi et al., (2019). Effect of Pregnancy on Some Biochemicaland Immunological Measures for Women with Toxoplasma Gondii. Biochem. Cell. Arch., 19(1), 761-765. DOI: 10.35124/bca.2019.19.1.761
  • Cenci-Goga, B. T., Rossitto, P. V., Sechi, P., McCrindle, C. M., & Cullor, J. S. (2011). Toxoplasma in Animals, Food, and Humans: An Old Parasite of New Concern. Foodborne Pathogens and Disease, 8(7), 751– 762. https://doi.org/10.1089/fpd.2010.0795
  • Darling, A. L., Rayman, M. P., Steer, C. D., Golding, J., Lanham-New, S. A., & Bath, S. C. (2017). Association between maternal VD status in pregnancy and neurodevelopmental outcomes in childhood: results from the Avon Longitudinal Study of Parents and Children (ALSPAC). British Journal of Nutrition, 117(12), 1682-1692.
  • Deschasaux, M., Souberbielle, J. C., Partula, V., Lécuyer, L., Gonzalez, R., Srour, B., Guinot, C., Malvy, D., Latino-Martel, P., Druesne- Pecollo, N., Galan, P., Hercberg, S., Kesse- Guyot, E., Fassier, P., Ezzedine, K., & Touvier, M. (2016). What Do People Know and Believe about Vitamin D? Nutrients, 8(11), 718. https://doi.org/10.3390/nu8110718
  • Elbahaie, E., Yousef, A., & Omar, M. (2022). Vitamin D3: Emerging Role in Murine Toxoplasmosis. Afro-Egyptian Journal of Infectious and Endemic Diseases, 12(1), 24-33. https://doi.org/10.21608/aeji.2021.96146.1180
  • Eyles, D., Burne, T., & McGrath, J. (2011, August). VD in fetal brain development. In Seminars in cell & developmental biology (Vol. 22, No. 6, pp. 629-636). Academic Press.
  • Fitzgerald, E., Hor, K., & Drake, A. J. (2020). Maternal influences on fetal brain development: The role of nutrition, infection and stress, and the potential for intergenerational consequences. Early Human Development, 150, 105190. https://doi.org/10.1016/j.earlhumdev.2020.105190
  • Gale, C. R., Robinson, S. M., Harvey, N. C., Javaid, M. K., Jiang, B., Martyn, C. N., ... & Cooper, C. (2008). Maternal VD status during pregnancy and child outcomes. European journal of clinical nutrition, 62(1), 68-77.
  • Goldstein, E. J., Montoya, J. G., & Remington, J. S. (2008). Management of Toxoplasma gondii infection during pregnancy. Clinical infectious diseases, 47(4), 554-566.
  • Hebert, K. J., Miller, L. L., & Joinson, C. J. (2010). Association of autistic spectrum disorder with season of birth and conception in a UK cohort. Autism Research, 3(4), 185– 190. https://doi.org/10.1002/aur.136
  • Hollis BW, Wagner CL. (2006). VD deficiency during pregnancy: an ongoing epidemic. Am J Clin Nutr., 84(2), 273.
  • Kim, H., Hong, S. H., Jeong, H. E., Han, S., Ahn, J., Kim, J. A., Yang, J. H., Oh, H. J., Chung, S., & Lee, S. E. (2022). Microfluidic model for in vitro acute Toxoplasma gondii infection and transendothelial migration. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-15305-4
  • Kinney, D. K., Hintz, K., Shearer, E. M., Barch, D. H., Riffin, C., Whitley, K., & Butler, R. (2010). A unifying hypothesis of schizophrenia: Abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction. Medical Hypotheses, 74(3), 555–563. https://doi.org/10.1016/j.mehy.2009.09.040
  • Kourtis, A. P., Read, J. S., & Jamieson, D. J. (2014). Pregnancy and Infection. New England Journal of Medicine, 370(23), 2211– 2218. https://doi.org/10.1056/nejmra1213566
  • Laboudi, M., Taghy, Z., Duieb, O., Peyron, F., & Sadak, A. (2021). Toxoplasma gondii seroprevalence among pregnant women in Rabat, Morocco. Tropical Medicine and Health, 49(1), 21-30. https://doi.org/10.1186/s41182-021-00311-5
  • Laird, E., Thurston, S. W., Van Wijngaarden, E., Shamlaye, C. F., Myers, G. J., Davidson, P. W., ... & Strain, J. J. (2017). Maternal VD status and the relationship with neonatal anthropometric and childhood neurodevelopmental outcomes: results from the Seychelles Child Development Nutrition Study. Nutrients, 9(11), 1235-1275.
  • McCann, J. C., & Ames, B. N. (2008). Is there convincing biological or behavioral evidence linking VD deficiency to brain dysfunction? FASEB J., 22(4), 982–1001.
  • Messerer, L., Bouzbid, S., & Gourbdji, E. et al. (2014). Séroprévalence de la toxoplasmose chez les femmes enceintes dans la wilaya d’Annaba, Algérie (Seroprevalence of toxoplasmosis in pregnant women in Annaba, Algeria). Rev Epidemiol Sante Publique, 62(2), 160–165.
  • Mirza Alizadeh, A., Jazaeri, S., Shemshadi, B., Hashempour-Baltork, F., Sarlak, Z., Pilevar, Z., & Hosseini, H. (2018). A review on inactivation methods of Toxoplasma gondii in foods. Pathogens and Global Health, 112(6), 306– 319. https://doi.org/10.1080/20477724.2018.1514137
  • Morales, E., Julvez, J., Torrent, M., Ballester, F., Rodriguez-Bernal, C. L., Andiarena, A., ... & Sunyera, J. (2015). VD in pregnancy and attention deficit hyperactivity disorder-like symptoms in childhood. Epidemiology, 26(4), 458-465.
  • Nazir, M. M., Akhtar, M., Maqbool, A., Waheed, A., Sajid, M. A., Ali, M. A., Oneeb, M., Alam, M. A., Ahmad, A. N., Nazir, N., Fatima, S., & Lindsay, D. S. (2017). Antibody Prevalence and Risk Factors for Toxoplasma gondiiInfection in Women from Multan, Pakistan. Zoonoses and Public Health, 64(7), 537–542. https://doi.org/10.1111/zph.12336
  • Pérez-López, F. R., Pilz, S., & Chedraui, P. (2020). VD supplementation during pregnancy: an overview. Current Opinion in Obstetrics and Gynecology, 32(5), 316-321.
  • Rasheed, Z., Shariq, A., AlQefari, G. B., Alwahbi, G. S., Aljuaythin, A. I., Alsuhaibani, F. S., Alotaibi, D. F., Aljohani, S. S., Alghasham, R., Alsaeed, T., Alharbi, N. A., Rugaie, O. A., Abdulmonem, W. A., & Sharaf, O. F. (2021). Toxoplasmosis in immunocompetent Saudi women: Correlation with vitamin D. Women’s Health, 17, 174550652110438. https://doi.org/10.1177/17455065211043844
  • Robert-Gangneux, F., & Darde, M. L. (2012). Epidemiology of and Diagnostic Strategies for Toxoplasmosis. Clinical Microbiology Reviews, 25, 264-296. https://doi.org/10.1128/CMR.05013-11
  • Sappenfield, E., Jamieson, D. J., & Kourtis, A. P. (2013). Pregnancy and Susceptibility to Infectious Diseases. Infectious Diseases in Obstetrics and Gynecology, 2013, 1– 8. https://doi.org/10.1155/2013/752852
  • Wagner, C. L., McNeil, R. B., Johnson, D. D., Hulsey, T. C., Ebeling, M., Robinson, C., ... & Hollis, B. W. (2013). Health characteristics and outcomes of two randomized VD supplementation trials during pregnancy: a combined analysis. The Journal of steroid biochemistry and molecular biology, 136, 313-320.
  • Whitehouse, A. J., Holt, B. J., Serralha, M., Holt, P. G., Kusel, M. M., & Hart, P. H. (2012). Maternal serum VD levels during pregnancy and offspring neurocognitive development. Pediatrics, 129(3), 485-493.
  • Willer, C. J., Dyment, D. A., Sadovnick, A. D., Rothwell, P. M., Murray, T. J., & Ebers, G. C. (2004). Timing of birth and risk of multiple sclerosis: population based study. BMJ, 330(7483), 120. https://doi.org/10.1136/bmj.38301.686030.63
  • Zhou, P., Chen, Z., Li, H. L., Zheng, H., He, S., Lin, R. Q., & Zhu, X. Q. (2011). Toxoplasma gondii infection in humans in China. Parasites &Amp; Vectors, 4(1). ttps://doi.org/10.1186/1756-3305-4-165

Cite this article

APA

    APA : Khan, S. A., Rehman, E., & Khattak, M. B. (2022). The Impact of Toxoplasma Gondii Infection on the Vitamin D3 Levels among Women in Childbearing Age, Treatment and Effect on Fetal Brain Development. Global Drug Design & Development Review, VII(II), 22-32. https://doi.org/10.31703/gdddr.2022(VII-II).04

CHICAGO

    CHICAGO : Khan, Sikandar Ali, Erum Rehman, and Muhammad Bilal Khattak. 2022. "The Impact of Toxoplasma Gondii Infection on the Vitamin D3 Levels among Women in Childbearing Age, Treatment and Effect on Fetal Brain Development." Global Drug Design & Development Review, VII (II): 22-32 doi: 10.31703/gdddr.2022(VII-II).04

HARVARD

    HARVARD : KHAN, S. A., REHMAN, E. & KHATTAK, M. B. 2022. The Impact of Toxoplasma Gondii Infection on the Vitamin D3 Levels among Women in Childbearing Age, Treatment and Effect on Fetal Brain Development. Global Drug Design & Development Review, VII, 22-32.

MHRA

    MHRA : Khan, Sikandar Ali, Erum Rehman, and Muhammad Bilal Khattak. 2022. "The Impact of Toxoplasma Gondii Infection on the Vitamin D3 Levels among Women in Childbearing Age, Treatment and Effect on Fetal Brain Development." Global Drug Design & Development Review, VII: 22-32

MLA

    MLA : Khan, Sikandar Ali, Erum Rehman, and Muhammad Bilal Khattak. "The Impact of Toxoplasma Gondii Infection on the Vitamin D3 Levels among Women in Childbearing Age, Treatment and Effect on Fetal Brain Development." Global Drug Design & Development Review, VII.II (2022): 22-32 Print.

OXFORD

    OXFORD : Khan, Sikandar Ali, Rehman, Erum, and Khattak, Muhammad Bilal (2022), "The Impact of Toxoplasma Gondii Infection on the Vitamin D3 Levels among Women in Childbearing Age, Treatment and Effect on Fetal Brain Development", Global Drug Design & Development Review, VII (II), 22-32

TURABIAN

    TURABIAN : Khan, Sikandar Ali, Erum Rehman, and Muhammad Bilal Khattak. "The Impact of Toxoplasma Gondii Infection on the Vitamin D3 Levels among Women in Childbearing Age, Treatment and Effect on Fetal Brain Development." Global Drug Design & Development Review VII, no. II (2022): 22-32. https://doi.org/10.31703/gdddr.2022(VII-II).04